GlassScriptPhysician profile
Merry Neville
NPI 1922659648
$5,044.25
in general payments reported to CMS, 2019-2025
13 companies · $2,526 in 2025
The $2,526 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $472 · 2022: $885 · 2023: $296 · 2024: $866 · 2025: $2,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,010 · Travel and Lodging: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,009.71 |
| Travel and Lodging | $677.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $2,133.72 | 2023-2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $1,653.08 | 2021-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Siemens Medical Solutions USA, INC. | $294.30 | 2021 | |
| Boston Scientific Corporation | $234.42 | 2021-2022 | |
| Pfizer INC. | $223.29 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $150.33 | 2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.60 | 2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.64 | 2024-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $58.96 | 2025 | Amvuttra |
| Invivyd INC | $54.71 | 2025 | Pemgarda |
| Atricure, INC. | $27.83 | 2022 | |
| Heartflow, INC. | $15.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merry Neville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.